Log in to save to my catalogue

Cost-Effectiveness Analysis of 68 Ga DOTA-TATE PET/CT, 111 In-Pentetreotide SPECT/CT and CT for Diag...

Cost-Effectiveness Analysis of 68 Ga DOTA-TATE PET/CT, 111 In-Pentetreotide SPECT/CT and CT for Diag...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_33670457

Cost-Effectiveness Analysis of 68 Ga DOTA-TATE PET/CT, 111 In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors

About this item

Full title

Cost-Effectiveness Analysis of 68 Ga DOTA-TATE PET/CT, 111 In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors

Publisher

Switzerland

Journal title

Diagnostics (Basel), 2021-02, Vol.11 (2)

Language

English

Formats

Publication information

Publisher

Switzerland

More information

Scope and Contents

Contents

Neuroendocrine tumors (NETs) are relatively rare neoplasms arising from the hormone-producing neuroendocrine system that can occur in various organs such as pancreas, small bowel, stomach and lung. As the majority of these tumors express somatostatin receptors (SSR) on their cell membrane, utilization of SSR analogs in nuclear medicine is a promisi...

Alternative Titles

Full title

Cost-Effectiveness Analysis of 68 Ga DOTA-TATE PET/CT, 111 In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_33670457

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_33670457

Other Identifiers

ISSN

2075-4418

E-ISSN

2075-4418

DOI

10.3390/diagnostics11020334

How to access this item